【発明の名称】タンパク質 - AstraZeneca UK Limited

Title:

【発明の名称】タンパク質

Document Type and Number:

Japanese Patent JP2002502610

Kind Code:

A

Abstract:

A novel human E3 ubiquitin protein ligase is provided as well as a nucleic acid structural region which encodes the polypeptide and the amino acid residue sequence of the human biomolecule. Methods are provided to identify compounds that modulate the biological activity of the molecule and hence regulate cellular and tissue physiology.

More Like This:

JP2001511246	INDUSTRIAL APPLICABILITY: Sampling instrument and sampling method
WO/2004/100977	INHIBITION OF TUMOR CELL PROLIFERATION BY FOXM1B INHIBITORS
JP5547947	A screening method of a sensitizing substance

Inventors:

Hustad, Carolin Margie's
Guild jar, namit

Application Number:

JP2000530615A

Publication Date:

January 29, 2002

Filing Date:

February 02, 1999

Export Citation:

Click for automatic bibliography generation Help

Assignee:

AstraZeneca UK Limited

International Classes:

G01N33/50; A61K31/7088; A61K45/00; A61K48/00; A61P3/10; A61P7/00; A61P19/02; A61P29/00; A61P31/12; A61P35/00; A61P37/02; C07K16/40; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N9/00; C12N15/09; C12Q1/68; G01N33/15; G01N33/68; A61K38/00; (IPC1-7): C12N15/09; A61K31/7088; A61K45/00; A61K48/00; A61P3/10; A61P7/00; A61P19/02; A61P29/00; A61P31/12; A61P35/00; A61P37/02; C07K16/40; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N9/00; C12Q1/68; G01N33/15; G01N33/50; G01N33/68

Attorney, Agent or Firm:

Kazuo Shamoto (5 outside)

Previous Patent: 真菌タンパク質の発現に重要な新規真菌タンパク質

Next Patent: ヒトヘパラナーゼポリペプチドおよびｃＤＮＡ